| Literature DB >> 31515709 |
Lidija Senerovic1, Dejan Opsenica2,3, Ivana Moric4, Ivana Aleksic4, Marta Spasić5, Branka Vasiljevic4.
Abstract
Infective diseases have become health threat of a global proportion due to appearance and spread of microorganisms resistant to majority of therapeutics currently used for their treatment. Therefore, there is a constant need for development of new antimicrobial agents, as well as novel therapeutic strategies. Quinolines and quinolones, isolated from plants, animals, and microorganisms, have demonstrated numerous biological activities such as antimicrobial, insecticidal, anti-inflammatory, antiplatelet, and antitumor. For more than two centuries quinoline/quinolone moiety has been used as a scaffold for drug development and even today it represents an inexhaustible inspiration for design and development of novel semi-synthetic or synthetic agents exhibiting broad spectrum of bioactivities. The structural diversity of synthetized compounds provides high and selective activity attained through different mechanisms of action, as well as low toxicity on human cells. This review describes quinoline and quinolone derivatives with antibacterial, antifungal, anti-virulent, antiviral, and anti-parasitic activities with the focus on the last 10 years literature.Entities:
Keywords: Anti-parasitics; Anti-virulence activity; Antibiotics; Antifungals; Antivirals; Quinoline/quinolone derivatives
Mesh:
Substances:
Year: 2020 PMID: 31515709 DOI: 10.1007/5584_2019_428
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622